The GBM classifier was validated as a stratifying method for pediatric and adult tumors, revealing consistent patterns across different tumor types (for example, favorable survival associated with MTC tumors) and context-dependent features (BRAF mutations and fusions associated with divergent metabolic subtypes in PG). This evidence concerns the gene BRAF and neoplasm.